Tags:BioTechCareDeliveryDevelopmentDiagnosticsDrugHealthMarketPharmacyPlatformProductScienceTechnology
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary formulation technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver enhanced formulations of their therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.
Total raised: $11.676323M
Founded date: 2007

Investors 6

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
31.03.2021Grant$3.859997M-marketscre...
10.09.2018-$7.816326M-cambridgen...

Mentions in press and media 96

DateTitleDescriptionCategoryAuthorSource
18.05.2022ARECOR TO ...Arecor Therapeutics plc (“Arec...--globenewsw...
28.04.2022ARECOR PRE...ARECOR PRESENTS FULL DATA FROM...--globenewsw...
12.04.2022Arecor Ann...Arecor Therapeutics plc (“Arec...--globenewsw...
23.03.2022ARECOR GRA...Arecor Therapeutics plc (“Arec...--globenewsw...
20.01.2022ARECOR COM...Arecor Therapeutics plc (“Arec...--globenewsw...
20.01.2022BUSINESS U...Arecor Therapeutics plc (“Arec...--globenewsw...
20.01.2022ARECOR COM...Arecor Therapeutics plc (“Arec...--marketscre...
14.12.2021Arecor ann...Arecor announces exclusive col...--cambridgen...
11.11.2021Arecor gra...Arecor granted key Canadian pa...--cambridgen...
01.11.2021Arecor ann...Arecor announces exclusive col...--cambridgen...
Show more